parkinsons cure glutathione Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Precursors and Beyond A review of the evidence
Description
Bos KJ, Holmes DF, Kadler KE, McLeod D, Morris NP, Bishop PN
In BV2 microglial cells, BV2-metformin-loaded PLGA treatment downregulated inducible nitric oxide synthase (iNOS) expression (proinflammatory M1 phenotype) and upregulated mannose receptor (CD206) expression (anti-inflammatory M2 phenotype), leading to a more than three-fold elevation in the CD206/iNOS fluorescence intensity ratio
Sheth, S
Kanaan RA, Oliver G, Dharan A, Sendi S, Maier A, Mohebbi M, et al
